Shopping Cart 0
Cart Subtotal
AED 0

Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Abiomed Inc (ABMD) Financial and Strategic SWOT Analysis Review provides you an in depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi annual financial statements published by the company for 5 interims history.

Highlights

Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company's heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc Key Recent Developments

May 03,2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year

Mar 30,2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp

Mar 05,2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations

Feb 13,2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery

Feb 01,2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 About the Company 6

Abiomed Inc Key Facts 6

Abiomed Inc Key Employees 7

Abiomed Inc Key Employee Biographies 8

Abiomed Inc Major Products and Services 9

Abiomed Inc History 10

Abiomed Inc Company Statement 13

Abiomed Inc Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2 Company Analysis 16

Company Overview 16

Abiomed Inc Business Description 17

Abiomed Inc Corporate Strategy 18

Abiomed Inc SWOT Analysis 19

SWOT Analysis Overview 19

Abiomed Inc Strengths 19

Abiomed Inc Weaknesses 20

Abiomed Inc Opportunities 21

Abiomed Inc Threats 22

Abiomed Inc Key Competitors 23

Section 3 Company Financial Ratios 24

Financial Ratios Capital Market Ratios 24

Financial Ratios Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios Interim Ratios 29

Financial Ratios Ratio Charts 30

Section 4 Company's Lifesciences Financial Deals and Alliances 31

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

Abiomed Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 32

Abiomed Inc, Recent Deals Summary 33

Section 5 Company's Recent Developments 34

May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year 34

Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 35

Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 36

Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery 37

Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 38

Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 39

Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 40

Oct 19, 2017: Abiomed's Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations 41

Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 42

Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 43

Section 6 Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Abiomed Inc, Performance Chart (2014 2018) 28

Abiomed Inc, Ratio Charts 30

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 32


List Of Table

List of Tables

Abiomed Inc, Key Facts 6

Abiomed Inc, Key Employees 7

Abiomed Inc, Key Employee Biographies 8

Abiomed Inc, Major Products and Services 9

Abiomed Inc, History 10

Abiomed Inc, Subsidiaries 15

Abiomed Inc, Key Competitors 23

Abiomed Inc, Ratios based on current share price 24

Abiomed Inc, Annual Ratios 25

Abiomed Inc, Annual Ratios (Cont...1) 26

Abiomed Inc, Annual Ratios (Cont...2) 27

Abiomed Inc, Interim Ratios 29

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

Abiomed Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 32

Abiomed Inc, Recent Deals Summary 33

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Abiomed Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Terumo Heart, Inc.

Teleflex Inc

TandemLife

Medtronic Plc

Maquet Cardiovascular LLC

Jarvik Heart Inc

HeartWare International Inc

Getinge AB

Edwards Lifesciences Corp

Boston Scientific Corp

Abbott Laboratories

Abiomed Inc (ABMD) Financial and Strategic SWOT Analysis Review provides you an in depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi annual financial statements published by the company for 5 interims history.

Highlights

Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company's heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc Key Recent Developments

May 03,2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year

Mar 30,2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp

Mar 05,2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations

Feb 13,2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery

Feb 01,2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 About the Company 6

Abiomed Inc Key Facts 6

Abiomed Inc Key Employees 7

Abiomed Inc Key Employee Biographies 8

Abiomed Inc Major Products and Services 9

Abiomed Inc History 10

Abiomed Inc Company Statement 13

Abiomed Inc Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2 Company Analysis 16

Company Overview 16

Abiomed Inc Business Description 17

Abiomed Inc Corporate Strategy 18

Abiomed Inc SWOT Analysis 19

SWOT Analysis Overview 19

Abiomed Inc Strengths 19

Abiomed Inc Weaknesses 20

Abiomed Inc Opportunities 21

Abiomed Inc Threats 22

Abiomed Inc Key Competitors 23

Section 3 Company Financial Ratios 24

Financial Ratios Capital Market Ratios 24

Financial Ratios Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios Interim Ratios 29

Financial Ratios Ratio Charts 30

Section 4 Company's Lifesciences Financial Deals and Alliances 31

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

Abiomed Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 32

Abiomed Inc, Recent Deals Summary 33

Section 5 Company's Recent Developments 34

May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year 34

Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 35

Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 36

Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery 37

Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 38

Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 39

Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 40

Oct 19, 2017: Abiomed's Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations 41

Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 42

Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 43

Section 6 Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Abiomed Inc, Performance Chart (2014 2018) 28

Abiomed Inc, Ratio Charts 30

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 32


List Of Table

List of Tables

Abiomed Inc, Key Facts 6

Abiomed Inc, Key Employees 7

Abiomed Inc, Key Employee Biographies 8

Abiomed Inc, Major Products and Services 9

Abiomed Inc, History 10

Abiomed Inc, Subsidiaries 15

Abiomed Inc, Key Competitors 23

Abiomed Inc, Ratios based on current share price 24

Abiomed Inc, Annual Ratios 25

Abiomed Inc, Annual Ratios (Cont...1) 26

Abiomed Inc, Annual Ratios (Cont...2) 27

Abiomed Inc, Interim Ratios 29

Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

Abiomed Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 32

Abiomed Inc, Recent Deals Summary 33

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Abiomed Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Terumo Heart, Inc.

Teleflex Inc

TandemLife

Medtronic Plc

Maquet Cardiovascular LLC

Jarvik Heart Inc

HeartWare International Inc

Getinge AB

Edwards Lifesciences Corp

Boston Scientific Corp

Abbott Laboratories

chat_bubbleLet's Chat